HS627
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HS627, covering 2025-11-21 to 2025-11-21. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Breast Cancer With Trastuzumab + HS627/ Pertuzumab + Docetaxel [Phase 3]